News
QLGN
--
0.00%
--
Qualigen to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
CARLSBAD, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announced today that CEO a...
GlobeNewswire · 09/15 11:30
Qualigen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announced today that CEO and Chairman Michael Poirier will present at the H.C. ...
GlobeNewswire · 09/08 11:30
QLGN: Focusing on Advancement of QN-247 and RAS-F…
By David Bautz, PhD NASDAQ:QLGN READ THE FULL QLGN RESEARCH REPORT
Benzinga · 09/05 11:00
ACST, AMSC and NETE among mid-day movers
Gainers: Regional Health Properties (NYSE:RHE) +55%. AC Immune (NASDAQ:ACIU) +34%. Net Element (NASDAQ:NETE) +27%. Vallon Pharmaceuticals (NASDAQ:VLON) +25%. Spok (NASDAQ:SPOK) +23%. Elys Game Technology (NASDAQ:ELYS) +21%. Youdao (NYSE:DAO) +20%. Qualigen
Seekingalpha · 08/31 16:54
Qualigen Therapeutics Shares See Volume; Zacks Small-Cap Research Sets $9 Valuation
https://s27.q4cdn.com/906368049/files/News/2021/Zacks_SCR_Research_08312021_QLGN_Bautz.pdf
Benzinga · 08/31 15:47
Regional Health Properties, AC Immune leads healthcare gainers; RenovoRx, Poseida Therapeutics among major losers
Gainers: Regional Health Properties (NYSE:RHE) +53%, AC Immune (NASDAQ:ACIU) +39%, Regencell Bioscience (NASDAQ:RGC) +29%, Qualigen Therapeutics (NASDAQ:QLGN) +19%, Reneo Pharmaceuticals (NASDAQ:RPHM) +17%. Losers: RenovoRx (NASDAQ:RNXT) -21%, Poseida Ther...
Seekingalpha · 08/31 15:11
4 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Benzinga · 08/23 13:58
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17)
Benzinga · 08/18 11:37
48 Stocks Moving In Tuesday's Mid-Day Session
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.
Benzinga · 08/17 16:03
Virpax Pharmaceuticals, Sesen Bio leads healthcare gainers; Qualigen Therapeutics, Sema4 among major losers
Gainers: Virpax Pharmaceuticals VRPX +96%, Sesen Bio (NASDAQ:SESN) +28%, Terns Pharmaceuticals (NASDAQ:TERN) +16%, 23andMe ME +16%, NanoVibronix (NASDAQ:NAOV) +9%. Losers: Qualigen Therapeutics QLGN -16%, Sema4 (NASDAQ:SMFR) -14%, AcelRx Pharmaceuticals (N...
Seekingalpha · 08/17 15:03
Why Qualigen Therapeutics (QLGN) Stock Plunging After Q2 Update
Benzinga · 08/17 14:01
BRIEF-Qualigen Therapeutics, Inc. Provides Update On Product Development Priorities And Reports Second Quarter And Six Month 2021 Financial Results
reuters.com · 08/17 12:54
Qualigen Therapeutics Q2 EPS $(0.18) Up From $(0.41) YoY, Sales $1.10M Up From $837.71K YoY
Qualigen Therapeutics (NASDAQ:QLGN) reported quarterly losses of $(0.18) per share. This is a 56.1 percent increase over losses of $(0.41) per share from the same period last year. The company reported $1.10 million in
Benzinga · 08/17 12:26
Qualigen Therapeutics Misses Q2 Estimates; Shifts Focus to Oncology Portfolio; Shares Decline
MT Newswires · 08/17 11:14
25 Stocks Moving in Tuesday's Pre-Market Session
Gainers Cardiol Therapeutics Inc. (NASDAQ: CRDL) shares rose 25.8% to $3.27 in pre-market trading after dropping around 7% on Monday.
Benzinga · 08/17 11:02
-- Earnings Flash (QLGN) QUALIGEN THERAPEUTICS Reports Q2 Revenue $1.1M
MT Newswires · 08/17 08:11
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
Benzinga · 07/19 21:30
VLDR, CLVS, WATT among pre-market gainers
Oxbridge (OXBR) +57%.Jiuzi (JZXN) +37%.Yunhong CTI (CTIB) +23%.AgriFORCE Growing  (AGRI) +14%.Scienjoy  (SJ) +12%.Qualigen Therapeutics (QLGN) +7%.Powerbridge (PBTS) +9%.China Online Edducation (COE) +8%.Clovis Oncology (CLVS) +8%.Forward Pharma (FWP) +8%....
Seekingalpha · 07/14 12:32
Qualigen Files US Application To Start Human Trials For COVID-19 Candidate
Benzinga · 07/14 12:27
Webull provides a variety of real-time QLGN stock news. You can receive the latest news about Qualigen Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About QLGN
Qualigen Therapeutics, Inc., formerly Ritter Pharmaceuticals, Inc., is a biotechnology company. The Company is focused on the development and commercialization of therapeutic products for the treatment of cancer and infectious diseases, as well as development of its FastPack diagnostic platform. Its pipeline includes AS1411, Aptamer Linked Anti Nucleolin (ALAN), Aptamer Linked Anti Nucleolin - Contrast Enhancement (ALAN-CE), Aptamer Linked Anti Nucleolin - Radiation Enhancement (ALAN-RE), Selective Target Antigen Removal System (STARS) and RAS-F. The FastPack System is an immunoassay testing system, which consists of the FastPack Analyzer and the FastPack test pouch, a single-use, disposable, foil packet which includes the FastPack reagent chemistry. The Company’s subsidiary is Qualigen, Inc.